CLEVELAND, March 29, 2017 /PRNewswire/ — After the release of their revolutionary new clinical trial management system, CTMS 360, DATATRAK is setting their sights on a new era of eClinical innovation, spearheaded by DATATRAK CEO and inventor of Electronic Data Capture, Jim Bob Ward.
“We created the industry with our EDC technology, revolutionized it with our CTMS, and will expand our coverage within the industry with what our team has been further developing,” says Ward. “Our enterprise architecture has been the cornerstone of our vision and the focus of our development since the beginning. Now it’s a matter of getting everything positioned for the greater Life Sciences market.”
While the plan is to continue to enhance DATATRAK‘s EDC and CTMS products, Ward emphasizes that these offerings were always critical pieces for a larger enterprise solution.
“We are expanding our current offerings by introducing imaging analyses, standardized APIs, upgrades to our design tools and reporting analytics,” says Vice President of Sales, Scott DeMell. “While we continue to expand our EDC and CTMS features, these will feed into our larger enterprise platform.”
A formal announcement on the specifics of the eClinical expansion is imminent, and will be published in advance of the upcoming DIA Annual Meeting in Chicago, which takes place in June. In anticipation of their growth into the greater enterprise market, DATATRAK is currently seeking to hire industry sales veterans to help with the expected growth. The company is encouraging qualified candidates to contact Laura Stuebbe at Laura.Stuebbe@datatrak.com.
As part of this growth, the DATATRAK corporate headquarters, located in Cleveland, Ohio, is being expanded to meet the growing needs of the organization and for personnel within the company. The expansion is expected to be completed in early April.
DATATRAK International is a worldwide technology and services company delivering cloud based eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform, designed to accelerate the reporting of clinical research, with greater efficiency compared to other similar technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I – Phase IV drug and device studies in multiple languages throughout the world. For more information, please visit DATATRAK.com.